Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Andy Schwab
AddedApr 2, 2024
UpdatedMay 31, 2026
Andy Schwab

Andy Schwab

Board Member, National Venture Capital Association

Crunchbase

Andy Schwab's Career

National Venture Capital Association
National Venture Capital Association

Washington, D.C., DC, US

Board Member· Board
5AM Ventures
5AM Ventures

Menlo Park, CA, US

Co-Founder
Pear Therapeutics
Pear Therapeutics

Boston, MA, US

Board Member· Board
Bird Rock Bio
Bird Rock Bio

Los Angeles, CA, US

Board Member· Board
Novome Biotechnologies
Novome Biotechnologies

South San Francisco, CA, US

Board Member· Board
CAMP4 Therapeutics
CAMP4 Therapeutics

Cambridge, MA, US

Board Member· Board
RareCyte
RareCyte

Seattle, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Andy Schwab's Career

National Venture Capital Association
National Venture Capital Association
NonprofitNonprofit721982Washington, D.C., DC, US
Board Member· Board

Recent news

a16z spends $1.49M in Washington lobbying, while rivals mostly sit outTechCrunch · 2025

Leadership at National Venture Capital Association

Jan GarfinkleJan GarfinkleBoard Member
Nick WashburnNick WashburnBoard Member
Vic ParkerVic ParkerBoard Member
Rob KettersonRob KettersonBoard Member
Jennifer TeganJennifer TeganBoard Member
Niten MalhanNiten MalhanBoard Member

Similar to National Venture Capital Association

Venture for AmericaVenture for AmericaNew York City, NY, USest. 2011Venture for AmericaNew York City, NY, US · est. 2011

Venture for America: A non-profit fostering economic growth in US cities through entrepreneurship training.

Nonprofit405
VentureWellVentureWellHadley, MA, USTrainingest. 1995VentureWellHadley, MA, US · est. 1995

VentureWell: Funding, training, and catalyzing student-led ventures for social and environmental impact.

Nonprofit143
Activation CapitalActivation CapitalRichmond, VA, USInnovation Programsest. 1993Activation CapitalRichmond, VA, US · est. 1993

Empowering innovation and talent in Richmond's ecosystem.

Nonprofit · $15M3
Western New York Venture AssociationWestern New York Venture AssociationBuffalo, NY, USBusiness, Investmentest. 1989Western New York Venture AssociationBuffalo, NY, US · est. 1989

WNY Venture Association: Promoting business and investment opportunities in Western New York.

Nonprofit1
5AM Ventures
5AM Ventures
Investment FirmInvestment Firm492002Menlo Park, CA, US
Co-Founder

Leadership at 5AM Ventures

John DiekmanJohn DiekmanCo-Founder

Similar to 5AM Ventures

Versant VenturesVersant VenturesSan Francisco, CA, USest. 1999Versant VenturesSan Francisco, CA, US · est. 1999

Versant Ventures: A leading healthcare investment firm, focusing on novel therapeutic biotechnology.

Investment Firm68
Atlas VentureAtlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29
Vida VenturesVida VenturesBoston, MA, USest. 2019Vida VenturesBoston, MA, US · est. 2019

Vida Ventures Advisors LLC: A bicoastal venture capital firm investing in life sciences, healthcare, and biotech.

Investment Firm29
Amkey VenturesAmkey VenturesFremont, CA, USest. 2001Amkey VenturesFremont, CA, US · est. 2001

Amkey Ventures, LLC: A US-based venture capital firm specializing in seed and start-up biotech investments.

Investment Firm6
Pear Therapeutics
Pear Therapeutics
Public$409M2002013Boston, MA, US
Board Member· Board

Leadership at Pear Therapeutics

William GreeneWilliam GreeneCo-Founder
Zack LynchZack LynchBoard Member
Eric LeuthardtEric LeuthardtBoard Member
Stephen SmithStephen SmithCo-Founder
Corey McCannCorey McCannCo-Founder
Bird Rock Bio
Bird Rock Bio

Los Angeles, CA, US

Board Member· Board
Novome Biotechnologies
Novome Biotechnologies
Series B$83.1M302016South San Francisco, CA, US
Board Member· Board

Leadership at Novome Biotechnologies

Will DeLoacheWill DeLoacheCo-Founder
Blake WiseBlake WiseBoard Member
Dan JanneyDan JanneyBoard Member
Weston WhitakerWeston WhitakerCo-Founder
Kiersten SteadKiersten SteadBoard Member
Zachary RussZachary RussCo-Founder

Similar to Novome Biotechnologies

Noveome BiotherapeuticsNoveome BiotherapeuticsPittsburgh, PA, USBiotherapeuticsest. 2000Noveome BiotherapeuticsPittsburgh, PA, US · est. 2000

Noveome Biotherapeutics: Clinical-stage company pioneering regenerative therapies for damaged tissues.

Series E · $43.3M24
Gemelli BiotechGemelli BiotechRaleigh, NC, USDiagnostics, Therapeuticsest. 2018Gemelli BiotechRaleigh, NC, US · est. 2018

Gemelli Biotech: Pioneering non-invasive diagnostics and therapeutics to unlock the potential of the human microbiome.

Series A · $28.4M2.5k
Petri BioPetri BioLos Angeles, CA, USTherapeuticsest. 2019Petri BioLos Angeles, CA, US · est. 2019

Petri Bio: A biotech firm innovating gut microbe-based therapeutics.

Seed · $255k3
Federation BioFederation BioSouth San Francisco, CA, USTreatmentsest. 2019Federation BioSouth San Francisco, CA, US · est. 2019

Federation Bio: Pioneering platforms for disease-targeting curative treatments via the human microbiome.

Series A · $50M46
CAMP4 Therapeutics
CAMP4 Therapeutics

Cambridge, MA, US

Board Member· Board
RareCyte
RareCyte

Seattle, WA, US

Board Member· Board

Andy Schwab's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Andy Schwab

Kush M. ParmarKush M. ParmarBoard Member · Entrada TherapeuticsJordan SelleckJordan SelleckFounder · 51 LabsRob KornblumRob KornblumBoard Member · CircleInLuke EvninLuke EvninBoard Member · DigiTx PartnersPeter BaerPeter BaerCo-Founder · TwigmoreChristian AngermayerChristian AngermayerFounder · re.Mind Capital